Australian Pharmaceutical Industries (ASX:API)
has released its 1H17 results, and reported its underlying NPAT rose 15% to $29.1 million.
The company also posted a 9% increase in earnings before interest and tax to $48.6 million.
API’s network includes Priceline Pharmacies and Soul Pattinson Chemists. Its Priceline pharmacy network grew to 450 stores, with 7.2% total retail network sales growth.
The company declared a fully-franked interim dividend of 3.5 cents per share, which is 40% higher than last year’s interim dividend.
This morning, API shares are tracking 0.5% higher at $2.05.